Report Detail

Request for Sample of this report

Medical Devices & Consumables Global Paclitaxel Drug-Eluting Balloon Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4544852
    • |
  • 25 July, 2023
    • |
  • Global
    • |
  • 105 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Paclitaxel Drug-Eluting Balloon market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Paclitaxel drug-eluting balloons are a type of medical device used in the treatment of peripheral artery disease (PAD). They are designed to deliver the drug paclitaxel to the affected area and reduce the risk of restenosis (re-narrowing of the artery).
This report is a detailed and comprehensive analysis for global Paclitaxel Drug-Eluting Balloon market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Paclitaxel Drug-Eluting Balloon market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Paclitaxel Drug-Eluting Balloon market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Paclitaxel Drug-Eluting Balloon market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Paclitaxel Drug-Eluting Balloon market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Paclitaxel Drug-Eluting Balloon
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Paclitaxel Drug-Eluting Balloon market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Boston Scientific, B. Braun, Cook Medical and Cardionovum, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Paclitaxel Drug-Eluting Balloon market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Balloon-Only Coating
Drug-Coated Balloon
Market segment by Application
Peripheral Artery Disease
Coronary Artery Disease
Major players covered
Medtronic
Boston Scientific
B. Braun
Cook Medical
Cardionovum
Aachen Resonance
QT Vascular
Biotronic
Philips
Eurocor
Yinyi Biotech
Lepu Medical Technology
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Paclitaxel Drug-Eluting Balloon product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Paclitaxel Drug-Eluting Balloon, with price, sales, revenue and global market share of Paclitaxel Drug-Eluting Balloon from 2018 to 2023.
Chapter 3, the Paclitaxel Drug-Eluting Balloon competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Paclitaxel Drug-Eluting Balloon breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Paclitaxel Drug-Eluting Balloon market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Paclitaxel Drug-Eluting Balloon.
Chapter 14 and 15, to describe Paclitaxel Drug-Eluting Balloon sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Paclitaxel Drug-Eluting Balloon
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Paclitaxel Drug-Eluting Balloon Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Balloon-Only Coating
    • 1.3.3 Drug-Coated Balloon
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Paclitaxel Drug-Eluting Balloon Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Peripheral Artery Disease
    • 1.4.3 Coronary Artery Disease
  • 1.5 Global Paclitaxel Drug-Eluting Balloon Market Size & Forecast
    • 1.5.1 Global Paclitaxel Drug-Eluting Balloon Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Paclitaxel Drug-Eluting Balloon Sales Quantity (2018-2029)
    • 1.5.3 Global Paclitaxel Drug-Eluting Balloon Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Medtronic
    • 2.1.1 Medtronic Details
    • 2.1.2 Medtronic Major Business
    • 2.1.3 Medtronic Paclitaxel Drug-Eluting Balloon Product and Services
    • 2.1.4 Medtronic Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Medtronic Recent Developments/Updates
  • 2.2 Boston Scientific
    • 2.2.1 Boston Scientific Details
    • 2.2.2 Boston Scientific Major Business
    • 2.2.3 Boston Scientific Paclitaxel Drug-Eluting Balloon Product and Services
    • 2.2.4 Boston Scientific Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Boston Scientific Recent Developments/Updates
  • 2.3 B. Braun
    • 2.3.1 B. Braun Details
    • 2.3.2 B. Braun Major Business
    • 2.3.3 B. Braun Paclitaxel Drug-Eluting Balloon Product and Services
    • 2.3.4 B. Braun Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 B. Braun Recent Developments/Updates
  • 2.4 Cook Medical
    • 2.4.1 Cook Medical Details
    • 2.4.2 Cook Medical Major Business
    • 2.4.3 Cook Medical Paclitaxel Drug-Eluting Balloon Product and Services
    • 2.4.4 Cook Medical Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Cook Medical Recent Developments/Updates
  • 2.5 Cardionovum
    • 2.5.1 Cardionovum Details
    • 2.5.2 Cardionovum Major Business
    • 2.5.3 Cardionovum Paclitaxel Drug-Eluting Balloon Product and Services
    • 2.5.4 Cardionovum Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Cardionovum Recent Developments/Updates
  • 2.6 Aachen Resonance
    • 2.6.1 Aachen Resonance Details
    • 2.6.2 Aachen Resonance Major Business
    • 2.6.3 Aachen Resonance Paclitaxel Drug-Eluting Balloon Product and Services
    • 2.6.4 Aachen Resonance Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Aachen Resonance Recent Developments/Updates
  • 2.7 QT Vascular
    • 2.7.1 QT Vascular Details
    • 2.7.2 QT Vascular Major Business
    • 2.7.3 QT Vascular Paclitaxel Drug-Eluting Balloon Product and Services
    • 2.7.4 QT Vascular Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 QT Vascular Recent Developments/Updates
  • 2.8 Biotronic
    • 2.8.1 Biotronic Details
    • 2.8.2 Biotronic Major Business
    • 2.8.3 Biotronic Paclitaxel Drug-Eluting Balloon Product and Services
    • 2.8.4 Biotronic Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Biotronic Recent Developments/Updates
  • 2.9 Philips
    • 2.9.1 Philips Details
    • 2.9.2 Philips Major Business
    • 2.9.3 Philips Paclitaxel Drug-Eluting Balloon Product and Services
    • 2.9.4 Philips Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Philips Recent Developments/Updates
  • 2.10 Eurocor
    • 2.10.1 Eurocor Details
    • 2.10.2 Eurocor Major Business
    • 2.10.3 Eurocor Paclitaxel Drug-Eluting Balloon Product and Services
    • 2.10.4 Eurocor Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Eurocor Recent Developments/Updates
  • 2.11 Yinyi Biotech
    • 2.11.1 Yinyi Biotech Details
    • 2.11.2 Yinyi Biotech Major Business
    • 2.11.3 Yinyi Biotech Paclitaxel Drug-Eluting Balloon Product and Services
    • 2.11.4 Yinyi Biotech Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Yinyi Biotech Recent Developments/Updates
  • 2.12 Lepu Medical Technology
    • 2.12.1 Lepu Medical Technology Details
    • 2.12.2 Lepu Medical Technology Major Business
    • 2.12.3 Lepu Medical Technology Paclitaxel Drug-Eluting Balloon Product and Services
    • 2.12.4 Lepu Medical Technology Paclitaxel Drug-Eluting Balloon Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Lepu Medical Technology Recent Developments/Updates

3 Competitive Environment: Paclitaxel Drug-Eluting Balloon by Manufacturer

  • 3.1 Global Paclitaxel Drug-Eluting Balloon Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Paclitaxel Drug-Eluting Balloon Revenue by Manufacturer (2018-2023)
  • 3.3 Global Paclitaxel Drug-Eluting Balloon Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Paclitaxel Drug-Eluting Balloon by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Paclitaxel Drug-Eluting Balloon Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Paclitaxel Drug-Eluting Balloon Manufacturer Market Share in 2022
  • 3.5 Paclitaxel Drug-Eluting Balloon Market: Overall Company Footprint Analysis
    • 3.5.1 Paclitaxel Drug-Eluting Balloon Market: Region Footprint
    • 3.5.2 Paclitaxel Drug-Eluting Balloon Market: Company Product Type Footprint
    • 3.5.3 Paclitaxel Drug-Eluting Balloon Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Paclitaxel Drug-Eluting Balloon Market Size by Region
    • 4.1.1 Global Paclitaxel Drug-Eluting Balloon Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Paclitaxel Drug-Eluting Balloon Consumption Value by Region (2018-2029)
    • 4.1.3 Global Paclitaxel Drug-Eluting Balloon Average Price by Region (2018-2029)
  • 4.2 North America Paclitaxel Drug-Eluting Balloon Consumption Value (2018-2029)
  • 4.3 Europe Paclitaxel Drug-Eluting Balloon Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Paclitaxel Drug-Eluting Balloon Consumption Value (2018-2029)
  • 4.5 South America Paclitaxel Drug-Eluting Balloon Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Paclitaxel Drug-Eluting Balloon Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Paclitaxel Drug-Eluting Balloon Sales Quantity by Type (2018-2029)
  • 5.2 Global Paclitaxel Drug-Eluting Balloon Consumption Value by Type (2018-2029)
  • 5.3 Global Paclitaxel Drug-Eluting Balloon Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Paclitaxel Drug-Eluting Balloon Sales Quantity by Application (2018-2029)
  • 6.2 Global Paclitaxel Drug-Eluting Balloon Consumption Value by Application (2018-2029)
  • 6.3 Global Paclitaxel Drug-Eluting Balloon Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Paclitaxel Drug-Eluting Balloon Sales Quantity by Type (2018-2029)
  • 7.2 North America Paclitaxel Drug-Eluting Balloon Sales Quantity by Application (2018-2029)
  • 7.3 North America Paclitaxel Drug-Eluting Balloon Market Size by Country
    • 7.3.1 North America Paclitaxel Drug-Eluting Balloon Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Paclitaxel Drug-Eluting Balloon Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Paclitaxel Drug-Eluting Balloon Sales Quantity by Type (2018-2029)
  • 8.2 Europe Paclitaxel Drug-Eluting Balloon Sales Quantity by Application (2018-2029)
  • 8.3 Europe Paclitaxel Drug-Eluting Balloon Market Size by Country
    • 8.3.1 Europe Paclitaxel Drug-Eluting Balloon Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Paclitaxel Drug-Eluting Balloon Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Paclitaxel Drug-Eluting Balloon Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Paclitaxel Drug-Eluting Balloon Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Paclitaxel Drug-Eluting Balloon Market Size by Region
    • 9.3.1 Asia-Pacific Paclitaxel Drug-Eluting Balloon Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Paclitaxel Drug-Eluting Balloon Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Paclitaxel Drug-Eluting Balloon Sales Quantity by Type (2018-2029)
  • 10.2 South America Paclitaxel Drug-Eluting Balloon Sales Quantity by Application (2018-2029)
  • 10.3 South America Paclitaxel Drug-Eluting Balloon Market Size by Country
    • 10.3.1 South America Paclitaxel Drug-Eluting Balloon Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Paclitaxel Drug-Eluting Balloon Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Paclitaxel Drug-Eluting Balloon Market Size by Country
    • 11.3.1 Middle East & Africa Paclitaxel Drug-Eluting Balloon Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Paclitaxel Drug-Eluting Balloon Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Paclitaxel Drug-Eluting Balloon Market Drivers
  • 12.2 Paclitaxel Drug-Eluting Balloon Market Restraints
  • 12.3 Paclitaxel Drug-Eluting Balloon Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Paclitaxel Drug-Eluting Balloon and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Paclitaxel Drug-Eluting Balloon
  • 13.3 Paclitaxel Drug-Eluting Balloon Production Process
  • 13.4 Paclitaxel Drug-Eluting Balloon Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Paclitaxel Drug-Eluting Balloon Typical Distributors
  • 14.3 Paclitaxel Drug-Eluting Balloon Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Paclitaxel Drug-Eluting Balloon. Industry analysis & Market Report on Paclitaxel Drug-Eluting Balloon is a syndicated market report, published as Global Paclitaxel Drug-Eluting Balloon Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Paclitaxel Drug-Eluting Balloon market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,773.56
    		4,160.34
    		5,547.12
    		3,236.40
    		4,854.60
    		6,472.80
    		532,022.40
    		798,033.60
    		1,064,044.80
    		290,336.40
    		435,504.60
    		580,672.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo